Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 167 citing articles:

The challenge of antimicrobial resistance: What economics can contribute
Laurence S. J. Roope, Richard Smith, Koen B. Pouwels, et al.
Science (2019) Vol. 364, Iss. 6435
Open Access | Times Cited: 438
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data
Eili Klein, Maja Milkowska-Shibata, Katie K Tseng, et al.
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 1, pp. 107-115
Open Access | Times Cited: 354
Antibiotic development — economic, regulatory and societal challenges
Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan, et al.
Nature Reviews Microbiology (2019) Vol. 18, Iss. 5, pp. 267-274
Open Access | Times Cited: 347
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries
Yingfen Hsia, Brian Lee, Ann Versporten, et al.
The Lancet Global Health (2019) Vol. 7, Iss. 7, pp. e861-e871
Open Access | Times Cited: 293
Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis
Giorgia Sulis, Pierrick Adam, Vaidehi Nafade, et al.
PLoS Medicine (2020) Vol. 17, Iss. 6, pp. e1003139-e1003139
Open Access | Times Cited: 200
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Brian Godman, Abiodun Egwuenu, Mainul Haque, et al.
Life (2021) Vol. 11, Iss. 6, pp. 528-528
Open Access | Times Cited: 179
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
Mike Sharland, Sumanth Gandra, Benedikt Huttner, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 12, pp. 1278-1280
Open Access | Times Cited: 150
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
Veronica Zanichelli, Mike Sharland, Bernadette Cappello, et al.
Bulletin of the World Health Organization (2023) Vol. 101, Iss. 04, pp. 290-296
Open Access | Times Cited: 112
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis
Giorgia Sulis, Brice Batomen, Anita Kotwani, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003682-e1003682
Open Access | Times Cited: 103
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries
Ines Pauwels, Ann Versporten, Nico Drapier, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 6, pp. 1614-1624
Open Access | Times Cited: 102
Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study
Chengsheng Ju, Li Wei, Kenneth K. C. Man, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e335-e346
Open Access | Times Cited: 78
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Lorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
Clinical Microbiology and Infection (2024) Vol. 30, pp. S1-S51
Open Access | Times Cited: 34
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future
Brian Godman, Mainul Haque, Judy McKimm, et al.
Current Medical Research and Opinion (2019) Vol. 36, Iss. 2, pp. 301-327
Open Access | Times Cited: 141
Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys
Günther Fink, Valérie D’Acremont, Hannah H. Leslie, et al.
The Lancet Infectious Diseases (2019) Vol. 20, Iss. 2, pp. 179-187
Closed Access | Times Cited: 137
Antimicrobial Resistance in Escherichia coli Strains Isolated from Humans and Pet Animals
Nikola Puvača, Rosa de Llanos
Antibiotics (2021) Vol. 10, Iss. 1, pp. 69-69
Open Access | Times Cited: 96
Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study
Ruth Brauer, Basmah H. Alfageh, Joseph E. Blais, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 12, pp. 1071-1082
Open Access | Times Cited: 94
Antibiotic-contaminated wastewater irrigated vegetables pose resistance selection risks to the gut microbiome
Fredrick Owino Gudda, Michael Gatheru Waigi, Emmanuel Stephen Odinga, et al.
Environmental Pollution (2020) Vol. 264, pp. 114752-114752
Closed Access | Times Cited: 88
State of the art methods and challenges of luminescent metal–organic frameworks for antibiotic detection
Rongrong Yuan, Hongming He
Inorganic Chemistry Frontiers (2020) Vol. 7, Iss. 22, pp. 4293-4319
Open Access | Times Cited: 87
Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research
Esmita Charani, Martin McKee, Raheelah Ahmad, et al.
The Lancet Regional Health - Europe (2021) Vol. 7, pp. 100161-100161
Open Access | Times Cited: 86
Trends in lipid-modifying agent use in 83 countries
Joseph E. Blais, Yue Wei, Kevin K.W. Yap, et al.
Atherosclerosis (2021) Vol. 328, pp. 44-51
Open Access | Times Cited: 82
Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): A multicentre observational study
Nienke N. Hagedoorn, Dorine Borensztajn, Ruud Nijman, et al.
PLoS Medicine (2020) Vol. 17, Iss. 8, pp. e1003208-e1003208
Open Access | Times Cited: 75
Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Brian Godman, Holly McCabe, Trudy Leong, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2020) Vol. 20, Iss. 1, pp. 1-26
Open Access | Times Cited: 69
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 59
Inner filter effect on amino-functionalized metal-organic framework for the selective detection of tetracycline
Crescentia Yazhini, Jithin Rafi, Paromita Chakraborty, et al.
Journal of Cleaner Production (2022) Vol. 373, pp. 133929-133929
Closed Access | Times Cited: 56
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries
Swathi Pathadka, Vincent Ka Chun Yan, Chin Fen Neoh, et al.
Drugs (2022) Vol. 82, Iss. 11, pp. 1193-1205
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top